Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

SapC-DOPS Technology May Help with Imaging Brain Tumors

May 15, 2014 By University of Cincinnati Academic Health Center

Just because you can’t see something doesn’t mean it’s not there.

Brain tumors are an extremely serious example of this and are not only difficult to treat—both adult and pediatric patients have a five-year survival rate of only 30 percent—but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process.

However, Cincinnati Cancer Center and University of Cincinnati Cancer Institute research studies published in an April online issue of the Journal of Magnetic Resonance Imaging and a May issue of the Journal of Visualized Experiments (JoVE), an online peer-reviewed scientific journal that publishes experimental methods in video format, reveal possibly new ways to image glioblastoma multiforme tumors—a form of brain tumor—using the SapC-DOPS technology.

A lysosomal protein saposin C (SapC), and a phospholipid, known as dioleoylphosphatidylserine (DOPS), can be combined and assembled into tiny cavities, or nanovesicles, to target and kill many forms of cancer cells.

Lysosomes are membrane-enclosed organelles that contain enzymes capable of breaking down all types of biological components; phospholipids are major components of all cell membranes and form lipid bilayers—or cell membranes.

Xiaoyang Qi, PhD, member of the CCC, associate professor in the division of hematology oncology at the University of Cincinnati, a member of the UC Cancer and Neuroscience Institutes and the Brain Tumor Center, says his lab and collaborators have previously found that the combination of two natural cellular components, called SapC-DOPS, caused cell death in cancer cell types, including brain, lung, skin, prostate, blood and breast cancer, while sparing normal cells and tissues.

“We used this knowledge to gain assistance from our collaborators Kati LaSance, Vontz Core Imaging Lab (VCIL) director, and Patrick Winter, PhD, in the Imaging Research Center (IRC) at Cincinnati Children’s Hospital Medical Center. We used SapC-DOPS as a transport vesicle to deliver bio-fluorescence agents and gadolinium-labeled contrast agents directly to brain tumors which provided visualization using optical imaging and MRI,” Qi says.

“There are two things lacking when it comes to brain tumors: getting a good picture of them and treating them effectively,” says LaSance. “With this discovery, there are possibilities to improve both. With good visualization of the tumor, physicians might one day be able to better determine which form of treatment—chemotherapy, radiation or surgery—would be best for a patient and can image a tumor at its smallest stages with hopes of intervening much earlier.”

Qi says this is preclinical research, as the studies were done using animal models that were injected with the SapC-DOPS vesicle assembled with illuminating agents, but is translational in nature and could be tested soon in human populations.

“While optical imaging is not applicable to a patient population, both MRI and PET imaging are,” he says. “The bio-fluorescent molecule used in the JoVE study can be substituted for a PET molecule and fortunately, PET imaging is widely used by doctors and hospitals in current cancer patients.

“This research has the potential to make a large impact in treatment of brain tumors, and most importantly, it would not have been impossible without support and collaboration from the VCIL and the IRC.”

Related Articles Read More >

CeQur Simplicity
CeQur is launching a discreet, convenient ‘wearable insulin pen’
Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I

DeviceTalks Weekly.

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech